US Stock MarketDetailed Quotes
INBX Inhibrx Biosciences
- 12.980
- -0.930-6.69%
Close Jul 18 16:00 ET
187.90MMarket Cap-1141P/E (TTM)
13.865High12.960Low186.07KVolume13.800Open13.910Pre Close2.47MTurnover2.34%Turnover RatioLossP/E (Static)14.48MShares18.95052wk High-17.45P/B103.16MFloat Cap12.61052wk Low--Dividend TTM7.95MShs Float18.950Historical High--Div YieldTTM6.51%Amplitude12.610Historical Low13.271Avg Price1Lot Size
Inhibrx Biosciences Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|
| Total revenue | 0 | 25.60%1.63M | 0 | 1.3M |
| Operating revenue | --0 | 25.60%1.63M | --0 | --1.3M |
| Cost of revenue | ||||
| Gross profit | ||||
| Operating expense | 24.46%49.21M | 32.37%154.38M | 39.54M | 116.62M |
| Selling and administrative expenses | 64.64%8.78M | 61.28%24.25M | --5.33M | --15.04M |
| -General and administrative expense | 64.64%8.78M | 61.28%24.25M | --5.33M | --15.04M |
| Research and development costs | 18.20%40.43M | 28.08%130.13M | --34.21M | --101.6M |
| Other operating expenses | ---- | ---- | ---- | ---14K |
| Operating profit | -24.46%-49.21M | -32.45%-152.75M | -39.54M | -115.32M |
| Net non-operating interest income expense | ||||
| Other net income (expense) | 15.71%-59K | -58,100.00%-580K | -70K | 1K |
| Other non- operating income (expenses) | 15.71%-59K | -58,100.00%-580K | ---70K | --1K |
| Income before tax | -24.39%-49.27M | -32.96%-153.33M | -39.61M | -115.32M |
| Income tax | 0.00%3K | 3K | ||
| Earnings from equity interest net of tax | ---- | ---1.63M | ---- | --0 |
| Net income | -24.39%-49.27M | -34.37%-154.96M | -39.61M | -115.33M |
| Net income continuous Operations | -24.39%-49.27M | -34.37%-154.96M | ---39.61M | ---115.33M |
| Minority interest income | ||||
| Net income attributable to the parent company | -24.39%-49.27M | -34.37%-154.96M | -39.61M | -115.33M |
| Preferred stock dividends | ||||
| Other preferred stock dividends | ||||
| Net income attributable to common stockholders | -24.39%-49.27M | -34.37%-154.96M | -39.61M | -115.33M |
| Basic earnings per share | -24.39%-3.4599 | -34.37%-10.8814 | -2.7814 | -8.098 |
| Diluted earnings per share | -24.39%-3.4599 | -34.37%-10.8814 | -2.7814 | -8.098 |
| Dividend per share | ||||
| Currency Unit | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
